Targeted immune therapy of ovarian cancer (Retraction of vol 34, pg 53, 2015)

Knutson Keith L.; Karyampudi Lavakumar; Lamichhane Purushottam; Preston Claudia

首页> 外文期刊>Cancer and Metastasis Reviews >Targeted immune therapy of ovarian cancer (Retraction of vol 34, pg 53, 2015)

【24h】

Targeted immune therapy of ovarian cancer (Retraction of vol 34, pg 53, 2015)

机译：针对卵巢癌的免疫治疗（卷34，PG 53,2015的收缩）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer and Metastasis Reviews》 |2016年第3期|共1页
作者
Knutson Keith L.; Karyampudi Lavakumar; Lamichhane Purushottam; Preston Claudia;
展开▼
作者单位

Vaccine &

Gene Therapy Inst Florida Canc Vaccines &

Immune Therapies Program Port St Lucie FL;

Vaccine &

Gene Therapy Inst Florida Canc Vaccines &

Immune Therapies Program Port St Lucie FL;

Vaccine &

Gene Therapy Inst Florida Canc Vaccines &

Immune Therapies Program Port St Lucie FL;

Mayo Clin Dept Immunol Rochester MN 55905 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Targeted immune therapy of ovarian cancer (Retraction of vol 34, pg 53, 2015) [J] . Knutson Keith L., Karyampudi Lavakumar, Lamichhane Purushottam, Cancer and Metastasis Reviews . 2016,第3期

机译：卵巢癌的靶向免疫疗法（第34卷撤消，第53页，2015年）
2. The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer (Retraction of vol 141, pg 1475, 2015) [J] . Bachmann Cornelia, Brucker Sara Y., Kraemer Bernard, Journal of Cancer Research and Clinical Oncology . 2016,第2期

机译：最佳细胞减少的晚期卵巢癌中淋巴结转移的预后相关性（第141卷撤回，第1475页，2015年）
3. Does ovarian stimulation for IVF increase gynaecological cancer risk? A systematic review and meta-analysis (Retraction of vol 31, pg 20, 2015) [J] . Zhao Jing, Li Yanping, Zhang Qiong, Reproductive biomedicine online . 2016,第4期

机译：卵巢刺激IVF是否会增加妇科癌症风险？系统评价和荟萃分析（第31卷的撤稿，第20页，2015年）
4. An image informatics pipeline for imaging mass cytometry to characterize the immune landscape in pre- and on-treatment immune therapy and its application in recurrent platinium-resistant epithelial ovarian cancer [C] . Ying Zhu, Tsz-Lun Yeung, Jianting Sheng, IEEE EMBS International Conference on Biomedical Health Informatics . 2019

机译：用于大规模细胞成像的图像信息学管线，用于表征治疗前和治疗中免疫治疗中的免疫情况及其在复发的铂耐药性上皮性卵巢癌中的应用
5. Adenovirus-basedp53 gene therapy: Intraperitoneal delivery for ovarian cancer. [D] . Carroll, Jennifer Lynette. 2002

机译：基于腺病毒的p53基因治疗：卵巢癌的腹膜内递送。
6. Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer [O] . Katherine Redd Bowman, Ji Hoon Kim, Carol S. Lim 2019

机译：缩小领域：线粒体靶向p53-BH3融合基因治疗卵巢癌的癌症特异性启动子
7. The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors [O] . Denisa Baci, Annalisa Bosi, Matteo Gallazzi, 2020

机译：卵巢癌肿瘤免疫微环境（时间）作为治疗靶标：重点是先天免疫细胞作为治疗效应

Targeted immune therapy of ovarian cancer (Retraction of vol 34, pg 53, 2015)

著录项

相似文献

相关主题

期刊订阅